Evolving Impact of COVID‐19 on Transplant Center Practices and Policies in the United StatesBrian J. Boyarsky, Jacqueline Garonzik‐Wang, Robin K. Avery et al.|Clinical Transplantation|2020Cited by 36
Impact of expanding HOPE Act experience criteria on program eligibility for transplantation from donors with human immunodeficiency virus to recipients with human immunodeficiency virusMary G. Bowring, Christine M. Durand, Jessica M. Ruck et al.|American Journal of Transplantation|2023Cited by 9
Perivaccination Antimetabolite Hold and Third Dose of SARS-CoV-2 Vaccine in Lung Transplant Recipients: Preliminary ReportSarah Frey, Pali D. Shah, Jessica M. Ruck et al.|Transplantation|2022Cited by 5
Antibody response to a third dose of SARS‐CoV‐2 vaccine in heart and lung transplant recipientsJennifer L. Alejo, William A. Werbel, Jessica M. Ruck et al.|Clinical Transplantation|2022Cited by 3
Trends over Time in Practice and Outcomes of Lung Transplantation in Recipients With Human Immunodeficiency VirusZeba Nauroz, Mary G. Bowring, Jessica M. Ruck et al.|Transplant Infectious Disease|2025Cited by 2